AstraZeneca Plc
(LSE) AZN
AstraZeneca Plc Financials at a Glance
Market Cap
£222.05B
Revenue (TTM)
$60.83B
Net Income (TTM)
$10.45B
EPS (TTM)
£4.96
P/E Ratio
28.65
Dividend
£2.36
Beta (Volatility)
-0.05 (Low)
Dividend
£2.36
Beta (Volatility)
-0.05 (Low)
Price
£143.18
Volume
3,946,267
Open
£140.38
Price
£143.18
Volume
3,946,267
Open
£140.38
Previous Close
£143.18
Daily Range
£139.00 - £143.26
52-Week Range
£101.04 - £157.30
Estimated Earnings Date
Jul 27, 2026
Dividend
£2.36
Beta (Volatility)
-0.05 (Low)
Price
£143.18
Volume
3,946,267
Open
£140.38
Previous Close
£143.18
Daily Range
£139.00 - £143.26
52-Week Range
£101.04 - £157.30
Estimated Earnings Date
Jul 27, 2026
AZN News
Coming Soon: AstraZeneca Earnings
10 Shares to Avoid Market Madness
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AstraZeneca Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
96,100
CEO
Pascal Soriot, MBA, DVM
Website
www.astrazeneca.comHeadquarters
Cambridge, CB2 0AA, GB
AZN Financials
Key Financial Metrics (TTM)
Gross Margin
79.71%
Operating Margin
23.53%
Net Income Margin
17.19%
Return on Equity
22.41%
Return on Capital
17.55%
Return on Assets
9.17%
Earnings Yield
3.49%
Dividend Yield
1.65%
Payout Ratio
46.98%
Stock Overview
Market Cap
£222.05B
Shares Outstanding
1.55B
Volume
3.95M
Avg. Volume
2.18M
Financials (TTM)
Gross Profit
$48.48B
Operating Income
$14.31B
EBITDA
$20.54B
Operating Cash Flow
$14.22B
Capital Expenditure
-$6.47B
Free Cash Flow
$7.75B
Cash & ST Invst.
$7.68B
Total Debt
$33.92B
AstraZeneca Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.29B
+9.5%
Gross Profit
$12.61B
+18.2%
Gross Margin
82.48%
N/A
Market Cap
£222.05B
N/A
Market Cap/Employee
£2.35M
N/A
Employees
94,300
N/A
Net Income
$3.08B
+2.8%
EBITDA
$5.67B
+9.5%
Quarterly Fundamentals
Total Cash
$7.68B
+41.9%
Total Debt
$33.92B
+8.4%
Accounts Receivable
$14.11B
-5.0%
Inventory
$6.57B
+11.4%
Long Term Debt
$25.96B
-6.9%
Short Term Debt
$7.96B
+133.7%
Return on Assets
9.17%
N/A
Return on Invested Capital
17.57%
N/A
Free Cash Flow
$1.82B
-33.6%
Operating Cash Flow
$3.36B
-9.5%